Ecolab produces and markets cleaning and sanitation products for the industrial manufacturing, data center, hospitality, healthcare, and life sciences markets... Show more
Ecolab Inc. (NYSE: ECL) closed near $288.53 in late October 2026, a gain of roughly 3% over the preceding 30 days and approximately 12% over the trailing quarter. With a market capitalization around $80 billion, the company trades at a premium valuation that reflects its reputation as a defensive, recurring-revenue compounder as well as its expanding exposure to artificial intelligence infrastructure. Broader sentiment has been constructive, though analysts have offered mixed views: some reiterated bullish ratings on the strength of the AI-linked water and cooling story, while others flagged elevated leverage and acquisition-related costs as reasons for caution.
Ecolab is a global leader in water, hygiene, and infection-prevention solutions and services, serving customers across more than 170 countries and 40 industries. Its roughly $16 billion in annual sales span core segments that include Global Water, Global Institutional & Specialty, Global Pest Elimination, and Global Life Sciences. The company's business model pairs specialty chemistry and equipment with on-site service and data-driven monitoring, creating recurring, contract-based revenue streams and deep customer relationships.
Investors have long followed Ecolab for its defensive characteristics, pricing power, and steady cash flow. In recent years, the company has leaned into faster-growing, higher-margin engines, including Global High-Tech (ultrapure water for semiconductors and data-center liquid cooling), Life Sciences, Pest Elimination, and Ecolab Digital. This combination of a stable installed base and emerging growth platforms has positioned Ecolab as both a quality compounder and, increasingly, a play on AI-driven infrastructure demand.
Ecolab's second-quarter 2026 results, reported in late July, showed reported sales growth of 10% to $4.4 billion, with organic sales growth accelerating to 5%. Adjusted diluted EPS of $2.09 rose 11% year over year, and management raised its full-year 2026 adjusted EPS outlook to $8.05–$8.25. Growth in the core business improved, led by Food & Beverage, Institutional, and Light Water, while growth engines such as Global High-Tech and Life Sciences continued to grow at double-digit rates.
The most consequential development has been the closing of the $4.75 billion acquisition of CoolIT Systems, a specialist in direct liquid cooling for high-density data centers. The deal positions Ecolab across the AI infrastructure value chain, from ultrapure water for chip manufacturing to liquid cooling for AI servers, building on the earlier acquisition of Ovivo Electronics. Management now targets roughly $4 billion in annual High-Tech sales by 2030, with operating margins near 25%.
These catalysts have supported the stock, but they have come with trade-offs. Total debt rose to about $13.2 billion at the end of the second quarter from $8.49 billion at the end of the first quarter, and higher interest expense and non-cash amortization tied to CoolIT are expected to weigh on near-term earnings. Bank of America reiterated a Buy rating and a $342 price objective in September, while other analysts have taken a more cautious stance given the more leveraged balance sheet.
Tickeron's Trending AI Robots page showcases a curated selection of AI-driven trading bots that operate across thousands of tickers. Tickeron offers hundreds of automated trading systems, but only the top-performing and most relevant bots appear in this section, making it a focused starting point for traders exploring algorithmic strategies. The bots vary widely by strategy, timeframe, and performance metrics, ranging from short-term momentum models to longer-horizon trend systems, so users can compare approaches suited to different objectives. Because each bot's parameters and results differ, reviewing individual performance data is essential before making decisions. Explore Trending AI Robots to see which automated strategies currently stand out.
Looking ahead, several factors will shape Ecolab's trajectory. The integration and ramp of CoolIT and Ovivo Electronics will be central to the story, as investors assess whether the High-Tech platform can sustain its above-25% growth pace and move toward the 2030 sales and margin targets. Ecolab's third-quarter 2026 results, expected around late October, will provide a key checkpoint on pricing, organic volume, and whether higher commodity costs are being offset as the company's energy surcharge takes full effect.
Investors should also monitor the balance sheet, as elevated debt and acquisition-related financing costs remain the clearest near-term risk. Macroeconomic conditions, including geopolitical disruption, industrial demand in Heavy Water and Paper, and commodity and energy volatility, could influence margins. On the positive side, continued strength in Life Sciences, Ecolab Digital, and Pest Elimination, along with the long-running 12%–15% adjusted EPS growth algorithm, offer a durable base for the broader narrative. As with any premium-valued industrial, the ability to deliver consistent execution will ultimately determine whether the current multiple is justified.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
The 10-day moving average for ECL crossed bullishly above the 50-day moving average on October 14, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 10 of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 71%.
ECL moved above its 50-day moving average on October 08, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +2.50% 3-day Advance, the price is estimated to grow further. Considering data from situations where ECL advanced for three days, in 171 of 327 cases, the price rose further within the following month. The odds of a continued upward trend are 52%.
The Aroon Indicator entered an Uptrend today. In 108 of 270 cases where ECL Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 40%.
The 10-day RSI Indicator for ECL moved out of overbought territory on November 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 48 similar instances where the indicator moved out of overbought territory. In 21 of the 48 cases, the stock moved lower in the following days. This puts the odds of a move lower at 44%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 37 of 68 cases where ECL's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 54%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ECL declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 52%.
ECL broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Price Growth Rating for this company is 24 (best 1 - 100 worst), indicating outstanding price growth. ECL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 34 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 43 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock slightly better than average.
The Tickeron SMR rating for this company is 45 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 90 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (8.382) is normal, around the industry mean (2.284). P/E Ratio (40.091) is within average values for comparable stocks, (-17.137). Projected Growth (PEG Ratio) (2.525) is also within normal values, averaging (1.548). Dividend Yield (0.010) settles around the average of (0.039) among similar stocks. P/S Ratio (4.621) is also within normal values, averaging (48.960).
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a developer of cleaning, sanitizing, pest control, maintenance and repair products and services
Industry ChemicalsSpecialty